X-Gen Pharmaceuticals, Inc.
Horseheads, NY
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 300 Daniel Zenker Dr, Horseheads, NY 14845, USA
- Website
- x-gen.us
- Founded
- 2003
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Information Technology
- Software & Services
- Internet Software & Services
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $66,041 |
| FY2025 | $54,838 |
| FY2024 | $32,198 |
| FY2023 | $5,299 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Logistics Agency | $66,041 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| FKA West-Ward Pharmaceuticals | Berkeley Heights, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Stratus Pharmaceuticals Inc. | Miami, FL | 325412 Pharmaceutical Preparation Manufacturing |
| Pfizer Inc. | New York, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Nephron S.C Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| United Drug Supply Inc. | Morrisville, NC | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
X-Gen Pharmaceuticals, Inc. manufactures injectable pharmaceutical products and medical supplies for the federal government as a prime contractor, operating predominantly through full-and-open delivery orders with no set-aside designations. The company is a woman-owned small business headquartered in Horseheads, New York, classified under NAICS 325412 (Medicinal and Botanical Manufacturing) and PSC Drugs And Biologicals.
The vendor's federal footprint is dominated by Defense Logistics Agency Troop Support Medical, which accounts for 165 of 170 total prime awards (99% of award count) and 99% of distinct customer agencies served. X-Gen's product portfolio centers on injectable medications including rocuronium, amphotericin B, acetazolamide, and promethazine solutions, supplied in vials and solutions to support military medical readiness and armed forces treatment facilities. Representative recent awards include a $53,549.34 delivery order from DLA Troop Support Medical awarded June 17, 2025 for rocuronium, promethazine, amphotericin B, and acetazolamide injectables; a $31,702.04 delivery order from the same customer awarded June 17, 2024 for promethazine, rocuronium, amphotericin B, acetazolamide, and related medical items; and multiple smaller orders for individual injectable products ($12 to $603 per order) placed on a rolling basis. The Department of Veterans Affairs Veterans Integrated Service Network 12 holds two awards worth $20 million combined potential value, but these represent outliers in the portfolio; the vast majority of X-Gen's federal work trades in high-volume, low-dollar delivery orders ($12 to $53,000 per order) for specific pharmaceutical products.
X-Gen operates as a 100% prime contractor with no subcontract footprint. The vendor places 115 task orders worth $616 thousand combined potential value under Indefinite Delivery Contract SPM2D009D0010 and 49 task orders worth $173 thousand combined potential value under Indefinite Delivery Contract SPE2D019D0003. The combined potential value across all 170 awards stands at $1.03 billion, though obligated dollars to date total only $808 thousand (0.08% of potential), reflecting the highly fragmented nature of the award portfolio — X-Gen's average delivery order ceiling is approximately $6 thousand. Activity has grown from two awards in 2022 to eleven in 2024, with only one award recorded in the first half of 2026 and minimal recompete exposure (one award with ultimate completion in the next twenty-four months, valued at $54 thousand).
Quick answers
Is X-Gen Pharmaceuticals, Inc. registered in SAM.gov?
Yes. X-Gen Pharmaceuticals, Inc.'s SAM.gov registration is active through January 13, 2027.
What is X-Gen Pharmaceuticals, Inc.'s CAGE code?
X-Gen Pharmaceuticals, Inc.'s CAGE code is 4S9Z5, and its Unique Entity ID (UEI) is YNPZDQT71NL5.
Which contract vehicles does X-Gen Pharmaceuticals, Inc. hold?
X-Gen Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has X-Gen Pharmaceuticals, Inc. received in federal contracts?
Federal contracts obligated $54,838 to X-Gen Pharmaceuticals, Inc. in fiscal year 2025 and $158,376 in fiscal years 2023 through 2027.
How does X-Gen Pharmaceuticals, Inc. rank among federal contractors?
X-Gen Pharmaceuticals, Inc. ranked #38 in NAICS 325411 in FY2025.
What is X-Gen Pharmaceuticals, Inc.'s most recent federal award?
X-Gen Pharmaceuticals, Inc.'s most recent federal contract award is Rocuronium 100 MG/10 ML vial 10ML (SPE2D326F355J), from Medical Supply Chain (DLA), on August 6, 2026.
On GovTribe
See X-Gen Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors